Role of quantitative bone scanning in the assessment of bone turnover in patients with Charcot foot
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
19933988
PubMed Central
PMC2809280
DOI
10.2337/dc09-0950
PII: dc09-0950
Knihovny.cz E-zdroje
- MeSH
- diabetes mellitus 2. typu komplikace diagnostické zobrazování MeSH
- dospělí MeSH
- komplikace diabetu diagnostické zobrazování MeSH
- kosti a kostní tkáň diagnostické zobrazování metabolismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- neurologické poruchy chůze diagnostické zobrazování MeSH
- percepce MeSH
- radiofarmaka * MeSH
- radioisotopová scintigrafie MeSH
- senioři MeSH
- technecium 99mTc medronát * MeSH
- vibrace MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- radiofarmaka * MeSH
- technecium 99mTc medronát * MeSH
OBJECTIVE: To assess the new quantitative bone scan parameters as markers of Charcot neuroosteoarthropathy (CNO) activity. RESEARCH DESIGN AND METHODS: Forty-two patients with acute (n = 21) and nonacute (n = 21) CNO underwent quantitative bone scanning. Patients with acute CNO were followed for 3-12 months and bone scans were repeated after treatment. New quantitative parameters were assessed and compared with markers of bone turnover and with skin temperature difference (STD). RESULTS: Significant correlations between quantitative bone scan parameters and bone turnover markers were observed (all P < 0.05). These parameters decreased after treatment of CNO, and its reduction to the baseline value correlated with differences of bone turnover markers and STD (all P < 0.05). CONCLUSIONS: Our study suggests that bone scanning can be used not only for diagnosis of CNO but also for monitoring disease activity by quantitative bone scan parameters.
Zobrazit více v PubMed
Sanders LJ, Frykberg RG. Diabetic neuropathic osteoarthropathy: Charcot foot. In The High Risk Foot in Diabetes Mellitus Levin ME, O'Neal LW, Bowker JH. Eds. New York, Churchill Livingstone, 1991, p. 297– 338
Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabet Med 2005; 22: 1707– 1712 PubMed
Boulton AJ. The diabetic foot: from art to science: the 18th Camillo Golgi Lecture Diabetologia 2004; 47: 1343– 1353 PubMed
Armstrong DG, Lavery LA. Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. J Rehabil Res Dev 1997; 34: 317– 321 PubMed
Cavanagh PR, Young MJ, Adams JE, Vickers KL, Boulton AJ. Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care 1994; 17: 201– 209 PubMed
Lavery LA, Higgins KR, Lanctot DR, Constantinides GP, Zamorano RG, Armstrong DG, Athanasiou KA, Agrawal CM. Home monitoring of foot skin temperatures to prevent ulceration. Diabetes Care 2004; 27: 2642– 2647 PubMed
Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care 2000; 23: 796– 800 PubMed
Armstrong DG, Lavery LA, Liswood PJ, Todd WF, Tredwell JA. Infrared dermal thermometry for the high-risk diabetic foot. Phys Ther 1997; 77: 169– 177 PubMed
McGill M, Molyneaux L, Bolton T, Ioannou K, Uren R, Yue DK. Response of Charcot's arthropathy to contact casting: assessment by quantitative techniques. Diabetologia 2000; 43: 481– 484 PubMed